Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Clinical Research and Genomic Analysis on Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma with Chidamide Monotherapy

Yu Wu, MD & PhD, Juan Xu, MD, Yuan Tang, MD, Yongqian Jia, MD

Blood (2016) 128 (22): 5287.

https://doi.org/10.1182/blood.V128.22.5287.5287

Published: 2016

Journal Articles

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Blood (2016) 128 (22): 4882.

https://doi.org/10.1182/blood.V128.22.4882.4882

Published: 2016

Journal Articles

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Ling Pan, MD, PhD, Meng Chen, Yongqian Jia, MD, PhD, Xu Cui, MD, Ting Niu, MD, PhD, Hong Chang, MD, PhD, Hongbing Ma, MD, Jianjun Li, MD, Yuping Gong, MD, PhD, Xinchuan Chen, MD, Ting Liu, MD, PhD

Blood (2013) 122 (21): 5001.

https://doi.org/10.1182/blood.V122.21.5001.5001

Published: 2013

Journal Articles

This Is a Title In Title Case: Safety and Efficacy of Intravenous 4.5g/m2 Methotrexate over 90 Minutes for Hematological Malignancy with Cerebral Involvement

Ling Pan, MD, PhD, Meng Chen, Li Zhang, MD, PhD, Yongqian Jia, MD, PhD, Ting Niu, MD, PhD

Blood (2013) 122 (21): 5566.

https://doi.org/10.1182/blood.V122.21.5566.5566

Published: 2013

Journal Articles

An Escalated Dose of Bortezomib Plus Second Line Chemotherapy for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,

Yongqian Jia, MD, Bing Xiang, MD, Xiaodong Wang, MD, Jianjun Li, MD, Chuan He, MD, Yi Su, MD, Hong Lu, MD, Ting Niu, MD, Jie Huang, MD, Xinchuan Chen, MD, Xu Cui, MD, Yuping Gong, MD, PhD, Huanling Zhu, MD, Ting Liu, MD

Blood (2011) 118 (21): 3714.

https://doi.org/10.1182/blood.V118.21.3714.3714

Published: 2011

Journal Articles

Gemcitabine, L-Asparaginase, Ifosfamide, Dexamethasone and Etoposide (GLIDE) Regiment In Advanced or Refractory Aggressive NK/T Cell Lymphomas: A Pilot Study

Jie Ji, MD, Ting Liu, MD, Bing Xiang, MD, Yongqian Jia, MD

Blood (2011) 118 (21): 5208.

https://doi.org/10.1182/blood.V118.21.5208.5208

Published: 2011

Journal Articles

Sirolimus Combined with Dexamethasone for the Treatment of a Patient with Interferon Resistant Hydroa Vacciniform-Like Lymphoma

Zhigang Liu, MD, Yongqian Jia, MD, Yuping Gong, MD, PhD, Yong Guo, MD, Jiazhuo Liu, MD, Ting Liu, MD

Blood (2011) 118 (21): 4992.

https://doi.org/10.1182/blood.V118.21.4992.4992

Published: 2011

Journal Articles

Low Expression of hOCT1 May Be a Key Point Mediating Low Intracellular Imatinib Accumulation in Imatinib Mesylate Resistance K562 Cell Line.

Huanling Zhu, MD, Ting Liu, MD, Yongqian Jia, MD

Blood (2007) 110 (11): 4547.

https://doi.org/10.1182/blood.V110.11.4547.4547

Published: 2007

Journal Articles

Long Term Survival of Patients with Chronic Myelocytic Leukemia after Allogeneic Stem Cell Transplant Using a Reduced Intensity Regimen of Melphanlan, Lomustine and Cyclophosphamide.

Yongqian Jia, MD, Ting Liu, MD, Ting Niu, MD, PhD, Caigang Xu, MD, Wentong Meng, MD, Jianchun Lu, Hui Wang

Blood (2005) 106 (11): 5308.

https://doi.org/10.1182/blood.V106.11.5308.5308

Published: 2005

Journal Articles

Chronic Imatinib Mesylate Exposure Leads to Reduced Intracellular Drug Accumulation in K562 Cells Measured by High-Performance Liquid Chromatography.

Yongqian Jia, MD, Zhen Yan, MD, Huanling Zhu, MD, Ting Niu, MD, PhD, Tingting Zeng, PhD, Feng Nan, Mengzhi Liang, PhD

Blood (2005) 106 (11): 4431.

https://doi.org/10.1182/blood.V106.11.4431.4431

Published: 2005

NARROW

Clinical Research and Genomic Analysis on Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma with Chidamide Monotherapy

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

This Is a Title In Title Case: Safety and Efficacy of Intravenous 4.5g/m2 Methotrexate over 90 Minutes for Hematological Malignancy with Cerebral Involvement

An Escalated Dose of Bortezomib Plus Second Line Chemotherapy for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,

Gemcitabine, L-Asparaginase, Ifosfamide, Dexamethasone and Etoposide (GLIDE) Regiment In Advanced or Refractory Aggressive NK/T Cell Lymphomas: A Pilot Study

Sirolimus Combined with Dexamethasone for the Treatment of a Patient with Interferon Resistant Hydroa Vacciniform-Like Lymphoma

Low Expression of hOCT1 May Be a Key Point Mediating Low Intracellular Imatinib Accumulation in Imatinib Mesylate Resistance K562 Cell Line.

Long Term Survival of Patients with Chronic Myelocytic Leukemia after Allogeneic Stem Cell Transplant Using a Reduced Intensity Regimen of Melphanlan, Lomustine and Cyclophosphamide.

Chronic Imatinib Mesylate Exposure Leads to Reduced Intracellular Drug Accumulation in K562 Cells Measured by High-Performance Liquid Chromatography.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only